Skip to main content
. 2019 Aug 13;93(17):e00878-19. doi: 10.1128/JVI.00878-19

TABLE 2.

Comparison of IY7640 and oseltamivir efficacies against group 1 and 2 influenza A viruses as well as influenza B viruses using the CPE assay

Virus
EC50 (μM)
CPE assay
Plaque reduction assay, IY7640
Group Subtype Strain IY7640 Oseltamivir carboxylate
1 H1N1 A/Solomon Island/03/2006 0.7 206.5 0.76
A/Brisbane/59/2007 0.62 7.11 1.53
Seasonal/2008a 3.81 964.3 1.95
pH1N1 A/Korea/01/2009 (rK09) 1.95 2.17 1.58
A/Netherlands/602/2009 2.13 2.26 2.3
A/Korea/2785/2009a 7.1 1323 5.11
H5N1 A/chicken/IS/06/2006 (6:2)b 59.6 0.19 16.16
H9N2 A/chicken/Korea/01310/2001 33.39 0.63 52.23
2 H3N2 A/Wisconsin/67/2005 83.05 0.09 111.1
A/Brisbane/10/2007 110.7 493.7 1,108
A/Perth/16/2009 213.9 518.4 832.4
H7N9 A/Anhui/1/2013 (6:2)b 221 0.81 277.1
B_Victoria B/Brisbane/60/2008 39.68 3.25 213.7
B_Yamagata B/Wisconsin/01/2010 17.13 0.56 47.19
rg-virusc pH1N1 rK09/NA:Y275a 1.92 1,302 2.6
rK09/NA:Y275+V222a 4.79 1,991 3.73
a

The NA proteins of these viruses retained the Y275 signature, which promotes resistance to oseltamivir.

b

6:2 viruses were generated on the PR8 backbone.

c

rg-viruses were generated on the K09 backbone.